Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Neuralstem, Inc. (NASDAQ: CUR).

Full DD Report for CUR

You must become a subscriber to view this report.


Recent News from (NASDAQ: CUR)

Neuralstem reports Q1 results
Neuralstem (NYSEMKT: CUR ): Q1 EPS of -$0.14 More news on: Neuralstem, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
Source: SeekingAlpha
Date: May, 15 2018 07:07
Neuralstem Provides Business Update and Reports First Quarter 2018 Fiscal Results
GERMANTOWN, Md., May 15, 2018 (GLOBE NEWSWIRE) -- Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company focused on the development of nervous system therapies based on its neural stem cell technology, provides a business update and reported its financial results for the first quarter e...
Source: GlobeNewswire
Date: May, 15 2018 07:00
Neuralstem Announces Publication of Long-Term Follow-up Data on ALS in the Annals of Clinical and Translational Neurology
Post-hoc comparison of combined cohorts from Phase 1 and 2 trials vs. historical controls revealed statistically significant difference in scores in functional status and in a composite statistic combining survival and functional status in subjects receiving human spinal cord-derived neur...
Source: GlobeNewswire
Date: May, 03 2018 07:00
Neuralstem (CUR) Presents At ARM's 6th Cell & Gene Therapy Investor Day - Slideshow
The following slide deck was published by Neuralstem, Inc. in conjunction with this Read more ...
Source: SeekingAlpha
Date: April, 18 2018 16:02
Blog Exposure - Idera Pharma Announces Clinical Development Support Agreement with Pillar Partners Foundation
Stock Monitor: Neuralstem Post Earnings Reporting LONDON, UK / ACCESSWIRE / April 18, 2018 / Active-Investors.com has just released a free research report on Idera Pharma, Inc. (NASDAQ: IDRA ) ("Idera"). If you want access to this report all you need to do is sign up now by clicking ...
Source: ACCESSWIRE IA
Date: April, 18 2018 07:00
Midday Gainers / Losers (04/17/2018)
Gainers: CNET +42% . WMLP +21% . CIFS +21% . CLXT +20% . IIN +19% . NVLN +15% . IFON +15% . DPW +14% . CHEK +14% . GTHX +14% . More news on: ChinaNet Online Holdings, Inc., Westmoreland Resource Partners, LP, China Internet Nationwide Financial Services Inc...
Source: SeekingAlpha
Date: April, 17 2018 12:40
Today's Research Reports on Trending Tickers: Neuralstem and Immunomedics
NEW YORK, NY / ACCESSWIRE / April 11, 2018 / U.S. equities regained their footing on Tuesday, as trade tensions between the U.S. and China calmed after comments from the Chinese President Xi Jinping. The Dow Jones Industrial Average gained 1.79 percent to close at 24,408.00, while the S&...
Source: ACCESSWIRE IA
Date: April, 11 2018 08:30
Neuralstem to Present Clinical Update at the Alliance for Regenerative Medicine 6th Annual Cell & Gene Therapy Investor Day
GERMANTOWN, Md., April 11, 2018 (GLOBE NEWSWIRE) -- Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company developing novel treatments for nervous system diseases, today announced Karl Johe, Ph.D, Chief Scientific Officer of Neuralstem, will be providing a clinical update at the Allianc...
Source: GlobeNewswire
Date: April, 11 2018 07:00
Premarket Gainers as of 9:05 am (04/10/2018)
PAY +52%  on $3.4B go-private deal via Francisco Partners. More news on: VeriFone Systems, Inc., Energous Corp., Spectrum Pharmaceuticals, Inc., Stocks on the move, , Read more ...
Source: SeekingAlpha
Date: April, 10 2018 09:25
Neuralstem up 22% premarket on advancement of NSI-566
Thinly traded nano cap Neuralstem (NYSEMKT: CUR ) is up  22%  premarket on robust volume on the heels of its announcement that the first surgery in the second cervical injury cohort has been completed in its Phase 1 clinical trial assessing lead stem cell therapy candidate NSI-56...
Source: SeekingAlpha
Date: April, 10 2018 08:57

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-08-211.151.241.251.13129,960
2018-08-201.161.16011.191.1532,763
2018-08-171.181.18621.201.136719,478
2018-08-161.131.181.191.1337,889
2018-08-151.161.151.161.1322,612

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-08-217,74726,29429.4630Cover
2018-08-202,71421,87112.4091Cover
2018-08-171,1934,15428.7193Cover
2018-08-163,6908,32744.3137Short
2018-08-159355,18818.0224Cover

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on CUR.


About Neuralstem, Inc. (NASDAQ: CUR)

Logo for Neuralstem, Inc. (NASDAQ: CUR)

Not available

 

Contact Information

 

 

Current Management

  • Richard Garr / CEO, President

Current Share Structure

  • Market Cap: $25,620,424 - 05/15/2018
  • Issue and Outstanding: 15,160,014 - 02/28/2018

 


Recent Filings from (NASDAQ: CUR)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 15 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 15 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: April, 25 2018
Additional proxy soliciting materials - definitive
Filing Type: DEFA14AFiling Source: edgar
Filing Date: April, 25 2018
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: April, 02 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 02 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 16 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: February, 09 2018
Statement of beneficial ownership of common stock by certain persons
Filing Type: SC 13GFiling Source: edgar
Filing Date: February, 02 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: January, 24 2018

 

 


Daily Technical Chart for (NASDAQ: CUR)

Daily Technical Chart for (NASDAQ: CUR)


Stay tuned for daily updates and more on (NASDAQ: CUR)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: CUR)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in CUR is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. DD Report does not own any shares of CUR and does not buy, sell, or trade any shares of CUR. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: http://dd.report/disclaimer/